BenoitDTanoMDPhD

PubMed

• 62 citations
  The History and Physics of Heliox
  Dean R. Hess, James B Fink, Shekhar T. Venkataraman, In K. Kim, Timothy R Myers, Benoit D Tano> ;Respiratory Care. 2006 Jun 1
• Cost-effectiveness of Advair: fluticasone propionate and salmeterol combination.
  Benoit Tano, Dev S. Pathak, Stephen Hoffmann> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2003 Dec 1
• Meta-analysis of Hodgkin''s disease among farmers.
  Khuder, S. A., Mutgi, A. B., Schaub, E. A., Tano, B. D.> ;Scand J Work Environ Health. 1999 Oct

Journal Articles

• The history and physics of heliox  
  HESS Dean R. ; FINK James B. ; VENKATARAMAN Shekhar T. ; KIM In K. ; MYERS Timothy R. TANO Benoit D, Respiratory Care, 1/1/2006
• Cost-Effectiveness of Advair (Fluticasone Propionate and Salmeterol Combination): A Review  
  Tano B, Hoffmann S, Pathak D., Expert Review of Pharmacoeconomics and Outcomes Research, 1/1/2003
• Meta-Analysis of Hodgkin's disease Among Farmers  
  Khuder, S. A., A. Mutgi, E. Schaub, B. Tano, Scandinavian Journal of Work and Environmental Health, 1/1/1999

Books/Book Chapters

• Layman's Guide To Integrative Immunity:Discover the 3 Keys to Maximum Health, Paperback 
  Benoit Tano, MDIntegrative Medical PressEdition 1st,2016
• The Layman’s Guide to Integrative Immunity: Discover the 3 Keys to Maximum Health, eBook 
  Tano BIntegrative Medical Press2016
• The Allergy Detective Series: Nasal Allergy Treatment Roadmap 
  Tano BIntegrative Medical Press2013
• Hormone Imbalance Syndrome: America’s Silent Plague 
  Tano BIntegrative Medical Press2012
• Allergic Rhinitis Treatment Secrets Your Doctor May Not Tell You 
  Tano BIntegrative Medical Press2011
• Join now to see all

Abstracts/Posters

• Heliox in the Treatment of Asthma and other Diagnoses: Evidence from a National Database
  Tano BD, Journal of Allergy and Clinical Immunology, 1/1/2011
• Heliox in the Treatment of Asthma and Other Diagnoses: Evidence from a National Database.
  Tano BD, Am J Respir Crit Care Med, 1/1/2009
• All That Wheezes is not Asthma: Misclassification, Comorbidities and Treatment Outcomes in Acute Asthma Exacerbations.
  Tano BD, Journal of Allergy and Clinical Immunology, 1/1/2008
• Race, asthma exacerbations and Leaving Against Medical Advice (LAMA)
  Tano BD, Journal of Allergy and Clinical Immunology, 1/1/2007
• Leaving Against Medical Advice (LAMA) in Asthma Exacerbation: Characteristics and Determinants of Leavers.
  B. Tano, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 11th Annual International Meeting, Philadelphia, PA, 1/20/2006
• Heliox in the Treatment of Patients Hospitalized for Asthma Exacerbations.
  Tano BD, Bilderback AL, Rand CS, Krishnan JA, AAAAI 62nd Annual Meeting, Miami Beach, FL, 1/3/2006
• Heliox in the Treatment of Patients Hospitalized for Asthma Exacerbations.
  Tano BD, Bilderback AL, Rand CS, Krishnan JA, Journal of Allergy and Clinical Immunology, 1/1/2006
• Leaving Against Medical Advice (LAMA) in Asthma Exacerbation: Characteristics and Determinants of Leavers.
  Tano BD, Value Health, 1/1/2006
• Transitions between Mild, Moderate and Severe Asthma States and Their Determinants: A Logistic Regression Approach.
  B. Tano, AAAAI 60th Annual Meeting, San Francisco, CA, 1/19/2004
• Budget Model for Estimating Economic Impact of Fluticasone Propionate/Salmeterol via Diskus® in an Adult Asthma Population.
  J. Mauskopf, T Shih, R.D. Borker, B. Tano, R. Stanford, P. Jhingran, AAAAI 60th Annual Meeting, San Francisco, CA, 1/19/2004
• Aggregating Cost Data from Multi-center Clinical Trials: An Incremental Cost-Effectiveness Elasticity Approach.
  Tano BD, Stanford R, Pathak D, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 9th Annual International Meeting, Arlington, VA, 1/1/2004
• Budget Model for Estimating Economic Impact of Fluticasone Propionate/Salmeterol via Diskus (R) in an Adult Asthma Population.
  J. Mauskopf, T Shih, R.D. Borker, B. Tano, R. Stanford, P. Jhingran, Journal of Allergy and Clinical Immunology, 1/1/2004
• Transitions between Mild, Moderate and Severe Asthma States and their Determinants: A Logistic Regression Approach.
  Tano BD, Journal of Allergy and Clinical Immunology, 1/1/2004
• Aggregating Cost Data from Multi-center Clinical Trials: An Incremental Cost-Effectiveness Elasticity Approach.
  Tano BD, Stanford R, Pathak D, Value Health, 1/1/2004
• Heliox in the Treatment of Status Asthmaticus in the ICU: A Cost-Effectiveness Analysis.
  Tano BD, Hoffmann S, Pathak D, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 6th Annual European Congress, Barcelona, Spain, 1/9/2003
• Treatment of Pulmonary Hypertension (PH): A Cost-Utility Analysis.
  Tano BD, Sood N, Hoffmann S, Pathak D, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 8th Annual International Meeting, Arlington, VA, 1/1/2003
• Treatment of Primary Pulmonary Hypertension (PPH): A Cost-utility Analysis.
  Tano BD, Sood N, Hoffmann S, Pathak D, Value Health, 1/1/2003
• Heliox in the Treatment of Status Asthmaticus: A Cost-effectiveness Analysis.
  Tano B D, Hoffmann S, Pathak D., Value Health, 1/1/2003
• Carcinoma of the Prostate: ``Latent” to ``Clinically Insignificant”. A Historical Perspective.
  Selman, S. H., B. Tano, Journal of Urology, 1/1/1999
• Which Calcium Channel Antagonist (CCA) is Superior in Hypertension? A Meta Analysis.
  Tano, B., B. Akpunonu, A. Mutgi, S. Khuder and D. Federman, Inter-American Society of Hypertension Meeting, Mexico City, 1/15/1997
• Which Calcium Channel Antagonist (CCA) is Superior in Hypertension? A Meta Analysis.
  Akpunonu, B. E., A. Mutgi, S. Khuder, D. Federman and B. Tano, Hypertension, 1/1/1997
• Join now to see all

Lectures

• Hormone Allergy. 
  Hospital Central Do Exercito, Divisao De Ensino E Pesquisa, Rio de Janeiro, Brazil - 1/22/2007
• T-Regulatory Cells in Allergy and Asthma 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/19/2006
• Heliox in the Treatment of Acute Asthma Exacerbation: A Cost-Effectiveness Analysis. 
  Imperial College London, South Kensington Campus - 1/18/2006
• Eosinophilic Esophagitis 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/14/2006
• COPD Outcomes Tools 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Heliox in the Treatment of Acute Asthma Exacerbation: A Cost-Effectiveness Analysis 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• A case of Severe Steroid-Dependent Asthma 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• All that Wheeze is not asthma: Diagnosis and Treatment of Concomitant Asthma and COPD 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Exercise-induced Anaphylaxis (EIA) and Urticaria 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Probiotics 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Progression of Asthma Measured by Lung Function in the Childhood Asthma Management Program (CAMP) 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Quality of Life Measures in Allergic Respiratory Diseases 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Venom Immunotherapy-induced Anaphylaxis 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2005
• Aggregating Cost Data from Multicenter Clinical Trials: An Incremental Cost-Effectiveness Elasticity Approach 
  Johns Hopkins Asthma And Allergy Center (JHAAC) - 1/1/2004
• Join now to see all